Plasma remnant-like particle lipid and apolipoprotein levels in normolipidemic and hyperlipidemic subjects

Atherosclerosis

Volumn 139, Issue 1, 1998, Pages 161-171

  Marcoux, Caroline ^a   Tremblay, Michel ^a   Fredenrich, Alexandre ^a   Jacques, Hélène ^a   Krimbou, Larbi ^a   Nakajima, Katsuyuki ^b   Davignon, Jean ^a   Cohn, Jeffrey S ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

Author keywords

Apolipoprotein; Hyperlipidemia; Low density lipoproteins; Remnant lipoproteins; Triglyceride rich lipoproteins

Indexed keywords

APOLIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; APOLIPOPROTEINS; BODY MASS INDEX; CHOLESTEROL; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEINS; LIPOPROTEINS, LDL; MALE; REFERENCE VALUES; TRIGLYCERIDES;

EID: 0032126317     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00042-2     Document Type: Article

References (38)

1. Gianturco S.H., Bradley W.A. Triglyceride-rich lipoproteins and their role in atherosclerosis. Curr Opin Lipidol. 2:1991;324-328.
2. Havel R. McCollum Award Lecture, 1993: Triglyceride-rich lipoproteins and atherosclerosis - new perspectives. Am J Clin Nutr. 59:1994;795-799.
3. Hamsten A. The hemostatic system and coronary heart disease. Thromb Res. 70:1993;1-38.
4. Havel R.J. Postprandial hyperlipidemia and remnant lipoproteins. Curr Opin Lipidol. 5:1994;102-109.
5. Nakajima K., Saito T., Tamura A., Suzuki M., Nakano T., Adachi M., Tanaka A., Tada N., Nakamura H., Campos E., Havel R.J. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels. Clin Chim Acta. 223:1993;53-71.
6. Campos E., Nakajima K., Tanaka A., Havel R.J. Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100. J Lipid Res. 33:1992;369-380.
7. Ikewaki K, Shige H, Nakajima K, Nakamura H. Postprandial remnant-like particles and coronary artery disease. In: Woodward FP, Davignon J, Sniderman A, editors. Atherosclerosis X. Amsterdam: Elsevier, 1995:200-202.
8. Shimizu H., Mori M., Sato T. An increase of serum remnant-like particles in noninsulin-dependent diabetic patients with microalbuminuria. Clin Chim Acta. 221:1993;191-196.
9. Nakajima K., Saito T., Tamura A., Suzuki M., Nakano T., Adachi M., Tanaka A., Tada N., Nakamura H., Murase T. A new approach for the detection of type III hyperlipoproteinemia by RLP-cholesterol assay. J Atheroscler Thromb. 1:1994;30-36.
10. Sekihara T., Nakano T., Nakajima K. High postprandial plasma remnant-like particles-cholesterol in patients with coronary artery diseases on chronic maintenance hemodialysis. Jpn J Nephrol. 38:1996;220-228.
11. Tanaka A., Ejiri N., Fujinuma Y., Yui K., Tamura M., Nakajima K., Morohoshi M., Fujisawa K., Uchimura I., Numano F. Remnant-like particles and restenosis of coronary arteries after PTCA. Ann NY Acad Sci. 748:1995;595-598.
12. Tomono S., Kawazu S., Kato N., Ono T., Ishii C., Ito Y., Shimizu M., Shimoyama M., Nakano T., Nakajima K. Uptake of remnant like particles (RLP) in diabetic patients from mouse peritoneal macrophages. J Atheroscler Thromb. 1:1994;98-102.
13. Knöfler R., Nakano T., Nakajima K., Takada Y., Takada A. Remnant-like lipoproteins stimulate whole blood platelet aggregation in vitro. Thromb Res. 78:1995;161-171.
14. Fredrickson DS, Goldstein JL, Brown MS. The familial hyperlipoproteinemias. In: Stanbury MF, Wyngaarden JB, Fredrickson DS, editors. The Metabolic Basis of Inherited Diseases. New York, NY: McGraw-Hill, 1978:604-655.
15. Cohn J.S., Tremblay M., Amiot M., Bouthillier D., Roy M., Genest J. Jr., Davignon J. Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects. Arterioscler Thromb Vasc Biol. 16:1996;149-159.
16. Nakajima K., Okazaki M., Tanaka A., Pullinger C.R., Wang T., Nakano T., Adachi M., Havel R.J. Separation and determination of remnant-like particles in human serum using monoclonal antibodies to apo B-100 and apo A-I. J Clin Ligand Assay. 19:1996;177-183.
17. Warnick G.R., Albers J.J. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res. 19:1978;65-76.
18. Hill J.S., Pritchard P.H. Improved phenotyping of apolipoprotein E: application to population frequency distribution. Clin Chem. 36:1990;1871-1874.
19. Fredenrich A., Giroux L.-M., Tremblay M., Krimbou L., Davignon J., Cohn J.S. Plasma lipoprotein distribution of apo C-III in normolipidemic and hyperlipidemic subjects: comparison of the apo C-III to apo E ratio in different lipoprotein fractions. J Lipid Res. 38:1997;1421-1432.
20. Albers J.J., Lodge M.S., Curtis L.K. Evaluation of a monoclonal antibody-based enzyme-linked immunosorbent assay as a candidate reference method for the measurement of apolipoprotein B-100. J Lipid Res. 30:1989;1445-1458.
21. Mackie A., Caslake M.J., Packard C.J., Shepherd J. Concentration and distribution of human plasma apolipoprotein E. Clin Chim Acta. 116:1981;35-45.
22. Castro G.R., Fielding C.J. Evidence for the distribution of apolipoprotein E between lipoprotein classes in human normocholesterolemic plasma and for the origin of unassociated apolipoprotein E (Lp-E). J Lipid Res. 25:1984;58-67.
23. Gibson J.C., Rubinstein A., Bukberg P.R., Brown W.V. Apolipoprotein E-enriched lipoprotein subclasses in normolipidemic subjects. J Lipid Res. 24:1983;886-898.
24. Schonfeld G., George P.K., Miller J., Reilly P., Witztum J. Apolipoprotein C-II and C-III levels in hyperlipoproteinemia. Metabolism. 28:1979;1001-1010.
25. Weintraub M.S., Eisenberg S., Breslow J.L. Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil. J Clin Invest. 79:1987;1110-1119.
26. Rubinsztein D.C., Cohen J.C., Berger G.M., van der Westhuyzen D.R., Coetzee G.A., Gevers W. Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defects. J Clin Invest. 86:1990;1306-1312.
27. Cohn J.S., Giroux L.-M., Fortin L.-J., Davignon J. Prevalence of double pre-beta lipoproteinemia in hyperlipidemic patients is influenced by gender, menopausal status and apo E phenotype. Arterioscler Thromb Vasc Biol. 17:1997;2630-2637.
28. Bijvoet S., Gagne S.E., Moorjani S., Gagne C., Henderson H.E., Fruchart J.C., Dallongeville J., Alaupovic P., Prins M., Kastelein J.J., Hayden M.R. Alterations in plasma lipoproteins and apolipoproteins before the age of 40 in heterozygotes for lipoprotein lipase deficiency. J Lipid Res. 37:1996;640-650.
29. Nestel P.J., Fidge N.H., Tan M.H. Increased lipoprotein-remnant formation in chronic renal failure. New Engl J Med. 307:1982;329-333.
30. Taskinen M.-R. Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus. Diabetes. 41:1992;12-17.
31. Tatami R., Mabuchi H., Ueda K., Ueda R., Haba T., Kametani T., Ho S., Koizumi J., Ohta M., Miyamoto S., Nakamaya A., Kanaya H., Gienda A., Takeda R. Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease. Circulation. 64:1981;1174-1184.
32. Reardon M.F., Nestel P.J., Craig I.H., Harper R.W. Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation. 71:1985;881-888.
33. Steiner G., Schwartz L., Shumak S., Poapst M. The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease. Circulation. 75:1987;124-130.
34. Fielding C.J., Castro G.R., Donner C., Fielding P.E., Reaven G.M. Distribution of apolipoprotein E in the plasma of insulin-dependent and noninsulin-dependent diabetics and its relation to cholesterol net transport. J Lipid Res. 27:1986;1052-1061.
35. Fielding C.J., Frohlich J., Moser K., Fielding P.E. Promotion of sterol efflux and net transport by apolipoprotein E in lecithin:cholesterol acyltransferase deficiency. Metabolism. 31:1982;1023-1028.
36. Huang Y., von Eckardstein A., Wu S., Maeda N., Assmann G. A plasma lipoprotein containing only apolipoprotein E and with γ mobility on electrophoresis releases cholesterol from cells. Proc Natl Acad Sci USA. 91:1994;1834-1838.
37. 2-LpE, and α-LpE. J Lipid Res. 38:1997;35-48.
38. McNamara J.R., Shah P.K., Nelson S.M., Nakajima K., Wilson P.W.F., Schaefer E.J. Lipoprotein remnant cholesterol and triglyceride values in coronary cases and Framingham controls. Circulation (abstract). 94:1996;I-94.